Latin America and the Caribbean Code Against Cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening
Prostate, breast, colorectal, cervical, and lung cancers are the leading cause of cancer in Latin America and the Caribbean (LAC) accounting for nearly 50% of cancer cases and cancer deaths in the region. Following the IARC Code Against Cancer methodology, a group of Latin American experts evaluated...
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés |
| Publicado: |
2023
|
| Materias: | |
| Acceso en línea: | http://repositorio.cedes.org/handle/123456789/4749 https://doi.org/10.1016/j.canep.2023.102446 |
| Aporte de: |
| id |
I61-R167-123456789-4749 |
|---|---|
| record_format |
dspace |
| spelling |
I61-R167-123456789-47492023-10-20T04:20:14Z Latin America and the Caribbean Code Against Cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening Baena, Armando Paolino, Melisa Villarreal-Garza, Cynthia Torres, Garbiela Delgado, Lucia Ruiz, Rossana Canelo-Aybar, Carlos Song, Yang Feliu, Ariadna Maza, Mauricio Jeronimo, Jose Espina, Carolina Almonte, Maribel Latin America Caribbean Region Neoplasms Hormone Replacement Therapy Early Detection of Cancer Prostate, breast, colorectal, cervical, and lung cancers are the leading cause of cancer in Latin America and the Caribbean (LAC) accounting for nearly 50% of cancer cases and cancer deaths in the region. Following the IARC Code Against Cancer methodology, a group of Latin American experts evaluated the evidence on several medical interventions to reduce cancer incidence and mortality considering the cancer burden in the region. A recommendation to limit the use of HRT was issued based on the risk associated to develop breast, endometrial, and ovarian cancer and on growing concerns related to the over-the-counter and without prescription sales, which in turn bias estimations on current use in LAC. In alignment with WHO breast and cervical cancer initiatives, biennial screening by clinical breast examination (performed by trained health professionals) from the age of 40 years and biennial screening by mammography from the age of 50 years to 74, as well as cervical screening by HPV testing (either self-sampling or provider-sampling) every 5–10 years for women aged 30–64 years, were recommended. The steadily increasing rates of colorectal cancer in LAC also led to recommend colorectal screening by occult blood testing every two years or by endoscopic examination of the colorectum every 10 years for both men and women aged 50–74 years. After evaluating the evidence, the experts decided not to issue recommendations for prostate and lung cancer screening; while there was insufficient evidence on prostate cancer mortality reduction by prostate-specific antigen (PSA) testing, there was evidence of mortality reduction by low-dose computed tomography (LDCT) targeting high-risk individuals (mainly heavy and/or long-term smokers) but not individuals with average risk to whom recommendations of this Code are directed. Finally, the group of experts adapted the gathered evidence to develop a competency-based online microlearning program for building cancer prevention capacity of primary care health professionals. 2023-10-19T20:18:41Z 2023-10-19T20:18:41Z 2023-10 Artículo http://repositorio.cedes.org/handle/123456789/4749 https://doi.org/10.1016/j.canep.2023.102446 en Cancer Epidemiology;Volume 86, Supplement 1, October 2023, 102446 |
| institution |
Centro de Estudios de Estado y Sociedad (CEDES) |
| institution_str |
I-61 |
| repository_str |
R-167 |
| collection |
Respositorio Digital CRIS del CEDES - Centro de Estudios de Estado y Sociedad |
| language |
Inglés |
| topic |
Latin America Caribbean Region Neoplasms Hormone Replacement Therapy Early Detection of Cancer |
| spellingShingle |
Latin America Caribbean Region Neoplasms Hormone Replacement Therapy Early Detection of Cancer Baena, Armando Paolino, Melisa Villarreal-Garza, Cynthia Torres, Garbiela Delgado, Lucia Ruiz, Rossana Canelo-Aybar, Carlos Song, Yang Feliu, Ariadna Maza, Mauricio Jeronimo, Jose Espina, Carolina Almonte, Maribel Latin America and the Caribbean Code Against Cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening |
| topic_facet |
Latin America Caribbean Region Neoplasms Hormone Replacement Therapy Early Detection of Cancer |
| description |
Prostate, breast, colorectal, cervical, and lung cancers are the leading cause of cancer in Latin America and the Caribbean (LAC) accounting for nearly 50% of cancer cases and cancer deaths in the region. Following the IARC Code Against Cancer methodology, a group of Latin American experts evaluated the evidence on several medical interventions to reduce cancer incidence and mortality considering the cancer burden in the region. A recommendation to limit the use of HRT was issued based on the risk associated to develop breast, endometrial, and ovarian cancer and on growing concerns related to the over-the-counter and without prescription sales, which in turn bias estimations on current use in LAC. In alignment with WHO breast and cervical cancer initiatives, biennial screening by clinical breast examination (performed by trained health professionals) from the age of 40 years and biennial screening by mammography from the age of 50 years to 74, as well as cervical screening by HPV testing (either self-sampling or provider-sampling) every 5–10 years for women aged 30–64 years, were recommended. The steadily increasing rates of colorectal cancer in LAC also led to recommend colorectal screening by occult blood testing every two years or by endoscopic examination of the colorectum every 10 years for both men and women aged 50–74 years. After evaluating the evidence, the experts decided not to issue recommendations for prostate and lung cancer screening; while there was insufficient evidence on prostate cancer mortality reduction by prostate-specific antigen (PSA) testing, there was evidence of mortality reduction by low-dose computed tomography (LDCT) targeting high-risk individuals (mainly heavy and/or long-term smokers) but not individuals with average risk to whom recommendations of this Code are directed. Finally, the group of experts adapted the gathered evidence to develop a competency-based online microlearning program for building cancer prevention capacity of primary care health professionals. |
| format |
Artículo |
| author |
Baena, Armando Paolino, Melisa Villarreal-Garza, Cynthia Torres, Garbiela Delgado, Lucia Ruiz, Rossana Canelo-Aybar, Carlos Song, Yang Feliu, Ariadna Maza, Mauricio Jeronimo, Jose Espina, Carolina Almonte, Maribel |
| author_facet |
Baena, Armando Paolino, Melisa Villarreal-Garza, Cynthia Torres, Garbiela Delgado, Lucia Ruiz, Rossana Canelo-Aybar, Carlos Song, Yang Feliu, Ariadna Maza, Mauricio Jeronimo, Jose Espina, Carolina Almonte, Maribel |
| author_sort |
Baena, Armando |
| title |
Latin America and the Caribbean Code Against Cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening |
| title_short |
Latin America and the Caribbean Code Against Cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening |
| title_full |
Latin America and the Caribbean Code Against Cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening |
| title_fullStr |
Latin America and the Caribbean Code Against Cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening |
| title_full_unstemmed |
Latin America and the Caribbean Code Against Cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening |
| title_sort |
latin america and the caribbean code against cancer 1st edition: medical interventions including hormone replacement therapy and cancer screening |
| publishDate |
2023 |
| url |
http://repositorio.cedes.org/handle/123456789/4749 https://doi.org/10.1016/j.canep.2023.102446 |
| work_keys_str_mv |
AT baenaarmando latinamericaandthecaribbeancodeagainstcancer1steditionmedicalinterventionsincludinghormonereplacementtherapyandcancerscreening AT paolinomelisa latinamericaandthecaribbeancodeagainstcancer1steditionmedicalinterventionsincludinghormonereplacementtherapyandcancerscreening AT villarrealgarzacynthia latinamericaandthecaribbeancodeagainstcancer1steditionmedicalinterventionsincludinghormonereplacementtherapyandcancerscreening AT torresgarbiela latinamericaandthecaribbeancodeagainstcancer1steditionmedicalinterventionsincludinghormonereplacementtherapyandcancerscreening AT delgadolucia latinamericaandthecaribbeancodeagainstcancer1steditionmedicalinterventionsincludinghormonereplacementtherapyandcancerscreening AT ruizrossana latinamericaandthecaribbeancodeagainstcancer1steditionmedicalinterventionsincludinghormonereplacementtherapyandcancerscreening AT caneloaybarcarlos latinamericaandthecaribbeancodeagainstcancer1steditionmedicalinterventionsincludinghormonereplacementtherapyandcancerscreening AT songyang latinamericaandthecaribbeancodeagainstcancer1steditionmedicalinterventionsincludinghormonereplacementtherapyandcancerscreening AT feliuariadna latinamericaandthecaribbeancodeagainstcancer1steditionmedicalinterventionsincludinghormonereplacementtherapyandcancerscreening AT mazamauricio latinamericaandthecaribbeancodeagainstcancer1steditionmedicalinterventionsincludinghormonereplacementtherapyandcancerscreening AT jeronimojose latinamericaandthecaribbeancodeagainstcancer1steditionmedicalinterventionsincludinghormonereplacementtherapyandcancerscreening AT espinacarolina latinamericaandthecaribbeancodeagainstcancer1steditionmedicalinterventionsincludinghormonereplacementtherapyandcancerscreening AT almontemaribel latinamericaandthecaribbeancodeagainstcancer1steditionmedicalinterventionsincludinghormonereplacementtherapyandcancerscreening |
| _version_ |
1809230814694604800 |